IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Cell sorting technology supports researchers advancing new therapies
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Subscribe To Our Newsletter & Stay Updated